Professional
Added to YB: 2025-03-14
Pitch date: 2025-03-12
CSBR [bullish]
Champions Oncology, Inc.
-28.81%
current return
Author Info
No bio for this author
Company Info
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States.
Market Cap
$93.8M
Pitch Price
$9.44
Price Target
12.00 (+79%)
Dividend
N/A
EV/EBITDA
14.06
P/E
31.87
EV/Sales
1.57
Sector
Life Sciences Tools and Services
Category
growth
Champions Oncology (CSBR): Strong Q3 Earnings Propel Craig-Hallum Price Target to $12
CSBR (increased price target): Craig-Hallum raises PT to $12 from $8, maintains Buy. Strong Q3 with $4.5M data licensing deal (up to $8M potential) from big pharma. Revenue $17M vs $12.9M est. Capitalizing on large data offerings to enhance drug development efficiency for customers.
Read full article (1 min)